Understanding G6PD's catalytic mechanisms has important clinical implications. For instance, screening for G6PD deficiency is crucial for preventing drug-induced hemolysis. Moreover, targeting G6PD has therapeutic potential in cancer treatment, as cancer cells rely heavily on the pentose phosphate pathway for NADPH production and maintaining redox balance.
